Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cardiac Marker Testing Market to reach USD 8.25 billion by the end of 2030

Global Cardiac Marker Testing Market Size Study & Forecast, by Product Type (Reagents and Kits, Instruments), by Biomarker Type (Troponin I and T, Creatine kinase-MB, Brain Natriuretic peptide, Other Cardiac Biomarkers), by Diseases (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Ischemia), by End User, and Regional Analysis, 2023-2030

Product Code: HLSMDE-38771618
Publish Date: 20-02-2024
Page: 200

Global Cardiac Marker Testing Market is valued at approximately USD 4.02 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 9.4% during the forecast period 2023-2030. Cardiac marker testing involves analyzing specific biomolecules released into the bloodstream in response to heart-related conditions, aiding in the diagnosis and assessment of cardiovascular diseases. These markers aid in diagnosing acute coronary syndromes, heart attacks, and other cardiac disorders. The testing is performed through blood tests to measure marker concentrations, with elevated levels indicating heart muscle damage. Cardiac marker testing is vital for early diagnosis, risk assessment, treatment monitoring, and ruling out or confirming acute myocardial infarction. It plays a pivotal role in cardiovascular medicine, contributing to timely interventions and improved patient outcomes. The rising clinical studies for the identification of novel cardiac biomarkers, the increase in geriatric population and subsequent escalation in heart conditions globally, cohesive government initiatives for the diagnosis of cardiac diseases, as well as growing funding initiatives from public and private organizations are the most prominent factors that are propelling the market demand across the globe.

In addition, the surge in incidences of cardiovascular diseases is directly associated with the demand for cardiac marker testing, which, in turn, augments the market growth at a substantial rate. The World Health Organization (WHO) reports that, with an estimated 17.9 million deaths worldwide each year, Cardiovascular Diseases (CVDs) are the world’s leading cause of mortality. In addition, 85% of these fatalities from cardiovascular disease are caused by heart attacks and strokes. As CVDs remain a leading cause of morbidity and mortality, the demand for diagnostic tools to identify and manage these conditions continues to grow. Furthermore, Ischemic Heart Disease (IHD) is a major cause of mortality worldwide, as per a study published in the Cureus Journal of Medical in July 2020 Science. Ischemic heart disease affects around 126 million individuals globally (1,655 per 100,000), or about 1.72% of the total population. It is predicted that there are more than 1,845 instances of ischemic heart disease per 100,000 individuals globally by 2030. Moreover, the ongoing research on novel cardiac biomarkers for cardiovascular diseases, as well as the soaring demand for Point-of-Care (POC) testing presents various lucrative opportunities over the forecast years. However, the technical issues related to sample collection and storage and several challenges associated with biomarker assay validation are hindering market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cardiac Marker Testing Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high cases of cardiovascular diseases, a rise in cardiac marker testing procedures, and the presence of well-established entities with robust portfolios in cardiac biomarker testing. Additionally, government backing for the exploration of new cardiac biomarkers is anticipated to provide further opportunities to the Cardiac Marker Testing Market across the region. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rise in the prevalence of Cardiovascular Diseases (CVD), an upsurge in testing procedures, advancements in healthcare infrastructure, and the widespread incorporation of advanced immunoassay technology in clinical laboratories are significantly propelling the market demand across the region. Furthermore, the Cardiac Marker Testing Market in the Asia Pacific is poised to benefit from the proliferation of local manufacturers providing testing products for cardiac markers and the expanding network of diagnostic laboratories in the region.

Major market players included in this report are:
F. Hoffmann-La Roche AG
Abbott Laboratories
Danaher Corporation
Siemens Healthineers AG
PerkinElmer, Inc.
BioMérieux SA
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Tosoh Corporation

Recent Developments in the Market:
Ø In October 2023, BD announced that the company had received the FDA’s approval for the utilization of its BD Vacutainer Troponin I Ultra test in point-of-care settings. This approval designates the BD Vacutainer Troponin I Ultra test as the pioneering and sole FDA-approved troponin test for on-the-spot diagnosis of Acute Myocardial Infarction (AMI).

Global Cardiac Marker Testing Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product Type, Biomarker Type, Diseases, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Reagents and Kits

By Biomarker Type:
Troponin I and T
Creatine kinase-MB(CK-MB)
Brain Natriuretic peptide (Bnp Or Nt-Probnp)
High-sensitivity C-reactive protein (hs-CRP)
Other Cardiac Biomarkers

By Diseases:
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome

By End User:
Laboratory Testing Facilities
Point-Of-Care Testing Facilities
Academic Institutions

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cardiac Marker Testing Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cardiac Marker Testing Market, by Product Type, 2020-2030 (USD Billion)
1.2.3. Cardiac Marker Testing Market, by Biomarker Type, 2020-2030 (USD Billion)
1.2.4. Cardiac Marker Testing Market, by Diseases, 2020-2030 (USD Billion)
1.2.5. Cardiac Marker Testing Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cardiac Marker Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cardiac Marker Testing Market Dynamics
3.1. Cardiac Marker Testing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Surge in incidences of cardiovascular diseases Cohesive government initiatives for the diagnosis of cardiac diseases
3.1.2. Market Challenges Technical issues related to sample collection and storage Challenges associated with biomarker assay validation
3.1.3. Market Opportunities Ongoing research on novel cardiac biomarkers for cardiovascular diseases Rising demand for point-of-care (POC) testing
Chapter 4. Global Cardiac Marker Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiac Marker Testing Market, by Product Type
5.1. Market Snapshot
5.2. Global Cardiac Marker Testing Market by Product Type, Performance – Potential Analysis
5.3. Global Cardiac Marker Testing Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4. Cardiac Marker Testing Market, Sub Segment Analysis
5.4.1. Reagents and Kits
5.4.2. Instruments
Chapter 6. Global Cardiac Marker Testing Market, by Biomarker Type
6.1. Market Snapshot
6.2. Global Cardiac Marker Testing Market by Biomarker Type, Performance – Potential Analysis
6.3. Global Cardiac Marker Testing Market Estimates & Forecasts by Biomarker Type 2020-2030 (USD Billion)
6.4. Cardiac Marker Testing Market, Sub Segment Analysis
6.4.1. Troponin I and T
6.4.2. Creatine kinase-MB(CK-MB)
6.4.3. Brain Natriuretic peptide (Bnp Or Nt-Probnp)
6.4.4. Myoglobin
6.4.5. High-sensitivity C-reactive protein(hs-CRP)
6.4.6. Other Cardiac Biomarkers
Chapter 7. Global Cardiac Marker Testing Market, by Diseases
7.1. Market Snapshot
7.2. Global Cardiac Marker Testing Market by Diseases, Performance – Potential Analysis
7.3. Global Cardiac Marker Testing Market Estimates & Forecasts by Diseases 2020-2030 (USD Billion)
7.4. Cardiac Marker Testing Market, Sub Segment Analysis
7.4.1. Myocardial Infarction
7.4.2. Congestive Heart Failure
7.4.3. Acute Coronary Syndrome
7.4.4. Atherosclerosis
7.4.5. Ischemia
Chapter 8. Cardiac Marker Testing Market, by End User
8.1. Market Snapshot
8.2. Global Cardiac Marker Testing Market by End User, Performance – Potential Analysis
8.3. Global Cardiac Marker Testing Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Cardiac Marker Testing Market, Sub Segment Analysis
8.4.1. Laboratory Testing Facilities
8.4.2. Point-Of-Care Testing Facilities
8.4.3. Academic Institutions
Chapter 9. Global Cardiac Marker Testing Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Cardiac Marker Testing Market, Regional Market Snapshot
9.4. North America Cardiac Marker Testing Market
9.4.1. U.S. Cardiac Marker Testing Market Product Type breakdown estimates & forecasts, 2020-2030 Biomarker Type breakdown estimates & forecasts, 2020-2030 Diseases breakdown estimates & forecasts, 2020-2030 End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Cardiac Marker Testing Market
9.5. Europe Cardiac Marker Testing Market Snapshot
9.5.1. U.K. Cardiac Marker Testing Market
9.5.2. Germany Cardiac Marker Testing Market
9.5.3. France Cardiac Marker Testing Market
9.5.4. Spain Cardiac Marker Testing Market
9.5.5. Italy Cardiac Marker Testing Market
9.5.6. Rest of Europe Cardiac Marker Testing Market
9.6. Asia-Pacific Cardiac Marker Testing Market Snapshot
9.6.1. China Cardiac Marker Testing Market
9.6.2. India Cardiac Marker Testing Market
9.6.3. Japan Cardiac Marker Testing Market
9.6.4. Australia Cardiac Marker Testing Market
9.6.5. South Korea Cardiac Marker Testing Market
9.6.6. Rest of Asia Pacific Cardiac Marker Testing Market
9.7. Latin America Cardiac Marker Testing Market Snapshot
9.7.1. Brazil Cardiac Marker Testing Market
9.7.2. Mexico Cardiac Marker Testing Market
9.8. Middle East & Africa Cardiac Marker Testing Market
9.8.1. Saudi Arabia Cardiac Marker Testing Market
9.8.2. South Africa Cardiac Marker Testing Market
9.8.3. Rest of Middle East & Africa Cardiac Marker Testing Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. F. Hoffmann-La Roche AG Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.3.2. Abbott Laboratories
10.3.3. Danaher Corporation
10.3.4. Siemens Healthineers AG
10.3.5. PerkinElmer, Inc.
10.3.6. BioMérieux SA
10.3.7. Becton, Dickinson and Company
10.3.8. Thermo Fisher Scientific Inc.
10.3.9. Bio-Rad Laboratories, Inc.
10.3.10. Tosoh Corporation
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now